Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.
Also called NCT01173094
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 130 participants
- Registry
-
NCT01173094
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01173094. Non-randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2013-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II)
- Acronym
- DCLI-II
- Condition
- Vascular Diseases
- Condition
- Diabetes
- Intervention (Device)
- Percutaneous Transluminal Angioplasty
- Intervention (Device)
- below-knee arterial bypass
- Lead sponsor
- Peking Union Medical College Hospital
- Collaborator
- Beijing Tongren Hospital
- Collaborator
- Xuanwu Hospital, Beijing
Record details
- Record id
cardio:ct-nct01173094- Content hash
4a292abf33ca1cbf2050eac84d07051d6cab0e032adcf343958b23b1d675b52d